PRVL
Citadel Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,417,690
| Closed | -$55.8M | – | 7128 |
|
|
2020
Q4 | $55.8M | Buy |
2,417,690
+3,622
| +0.2% | +$83.6K | 0.01% | 383 |
|
|
2020
Q3 | $24.6M | Buy |
2,414,068
+1,239,405
| +106% | +$12.6M | 0.01% | 664 |
|
|
2020
Q2 | $17.5M | Buy |
1,174,663
+2,866
| +0.2% | +$42.7K | 0.01% | 807 |
|
|
2020
Q1 | $14.3M | Buy |
1,171,797
+1,817
| +0.2% | +$22.1K | 0.01% | 802 |
|
|
2019
Q4 | $18.5M | Buy |
1,169,980
+100,003
| +9% | +$1.58M | 0.01% | 838 |
|
|
2019
Q3 | $13.1M | Sell |
1,069,977
-116,063
| -10% | -$1.43M | 0.01% | 1029 |
|
|
2019
Q2 | $15.7M | Buy |
+1,186,040
| New | +$15.7M | 0.01% | 929 |
|